BCM
IDXG

Bridgeway Capital Management’s Interpace Biosciences, Inc. Common Stock IDXG Stock Holding History

Bridgeway Capital Management’s Portfolio IDXG Stock Details IDXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-1,554
Closed -$77K – 1500
2015
Q4 		$77K Sell
1,554
-74
-5% -$8.24K ﹤0.01% 1384
2015
Q3 		$291K Buy
1,628
+1,250
+331% +$246K 0.01% 1225
2015
Q2 		$54K Hold
378
– – ﹤0.01% 1468
2015
Q1 		$51K Hold
378
– – ﹤0.01% 1455
2014
Q4 		$68K Sell
378
-300
-44% -$53.4K ﹤0.01% 1412
2014
Q3 		$163K Buy
678
+18
+3% +$6.01K ﹤0.01% 1363
2014
Q2 		$289K Hold
660
– – 0.01% 1260
2014
Q1 		$302K Hold
660
– – 0.01% 1242
2013
Q4 		$317K Buy
660
+250
+61% +$122K 0.01% 1210
2013
Q3 		$198K Hold
410
– – 0.01% 1318
2013
Q2 		$193K Buy
+410
New +$186K 0.01% 1277

Other funds holding IDXG

HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.69B AUM 19.05% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return